Cindy Li
Novartis (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Genetics and Biotechnology, Pharmaceutical and Antibiotic Environmental Impacts, Biochemical and Structural Characterization, Neurological diseases and metabolism
Most-Cited Works
- → Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228(2018)58 cited
- → Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae(2018)39 cited
- → Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity(2018)33 cited
- → In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae(2018)33 cited
- → Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria(2018)29 cited
- → Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight Limits(2019)28 cited
- → Morphological Deconvolution of Beta-Lactam Polyspecificity in E. coli(2019)24 cited
- → Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics(2017)15 cited
- → Impact of InducibleblaDHA-1on Susceptibility of Klebsiella pneumoniae Clinical Isolates to LYS228 and Identification of ChromosomalmplandampDMutations Mediating Upregulation of Plasmid-BorneblaDHA-1Expression(2018)10 cited